Kyu Saito - Hisamitsu Pharmaceutical Head Officer
HPX Stock | EUR 25.20 0.20 0.80% |
Insider
Kyu Saito is Head Officer of Hisamitsu Pharmaceutical Co
Age | 60 |
Phone | 81 3 5293 1720 |
Web | https://www.hisamitsu.co.jp |
Hisamitsu Pharmaceutical Management Efficiency
The company has return on total asset (ROA) of 0.0212 % which means that it generated a profit of $0.0212 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0504 %, meaning that it generated $0.0504 on every $100 dollars invested by stockholders. Hisamitsu Pharmaceutical's management efficiency ratios could be used to measure how well Hisamitsu Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Shuji Sugawara | Tsumura Co | N/A | |
Jun Yang | Guangzhou Baiyunshan Pharmaceut | 53 | |
Jianzhong Liu | CanSino Biologics | 55 | |
David Ricks | Elanco Animal Health | 50 | |
Yan Li | HANSOH PHARMAC HD 00001 | N/A | |
Qiang Xu | CanSino Biologics | 50 | |
Norimasa Takeda | Takeda Pharmaceutical | N/A | |
Shuifa Gui | CanSino Biologics | 54 | |
Christophe Weber | Takeda Pharmaceutical | 57 | |
Aaron Schacht | Elanco Animal Health | 51 | |
Jianxiong Zheng | Guangzhou Baiyunshan Pharmaceut | 53 | |
Barbara Weiland | Merck Company | 49 | |
Matthias Heinzel | Merck Company | 56 | |
Zhu Xin | CanSino Biologics | 50 | |
Koin Toda | Tsumura Co | N/A | |
Mitsuru Nakata | Tsumura Co | N/A | |
Shiu Wai | CanSino Biologics | 55 | |
Yuan Sun | HANSOH PHARMAC HD 00001 | 32 | |
Min Hu | HANSOH PHARMAC HD 00001 | 42 | |
Andrew Plump | Takeda Pharmaceutical | 58 | |
Carl McMillian | Elanco Animal Health | 51 |
Management Performance
Return On Equity | 0.0504 | |||
Return On Asset | 0.0212 |
Hisamitsu Pharmaceutical Leadership Team
Elected by the shareholders, the Hisamitsu Pharmaceutical's board of directors comprises two types of representatives: Hisamitsu Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hisamitsu. The board's role is to monitor Hisamitsu Pharmaceutical's management team and ensure that shareholders' interests are well served. Hisamitsu Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hisamitsu Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Kyu Saito, Head Officer | ||
Shinichiro Takao, Head MD | ||
Mitsutoshi Tsuruta, Ex Division | ||
Masaya Okuno, OTC Division | ||
Kazuhide Nakatomi, CEO Pres | ||
Koji Takiyama, Sr Director | ||
Kosuke Sugiyama, Exec MD | ||
Shinichi Murayama, Exec Director | ||
Nobuo Tsutsumi, Mgmt Dept | ||
Mitsumasa Kabashima, Pres Ltd |
Hisamitsu Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Hisamitsu Pharmaceutical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0504 | |||
Return On Asset | 0.0212 | |||
Profit Margin | 0.10 % | |||
Operating Margin | 0.09 % | |||
Current Valuation | 1.09 B | |||
Shares Outstanding | 79.53 M | |||
Shares Owned By Insiders | 26.45 % | |||
Shares Owned By Institutions | 35.29 % | |||
Price To Earning | 34.35 X | |||
Price To Book | 1.14 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Hisamitsu Stock
Hisamitsu Pharmaceutical financial ratios help investors to determine whether Hisamitsu Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hisamitsu with respect to the benefits of owning Hisamitsu Pharmaceutical security.